Go Pro

Bank of America Corp DE Boosts Stake in Synopsys, Inc. $SNPS

Synopsys logo with Technology background
Image from MarketBeat Media, LLC.

Bank of America Corp DE boosted its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 34.0% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,386,817 shares of the semiconductor company's stock after acquiring an additional 352,004 shares during the quarter. Bank of America Corp DE owned 0.72% of Synopsys worth $549,845,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Sankala Group LLC purchased a new position in Synopsys in the 4th quarter worth approximately $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of Synopsys during the 4th quarter valued at $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys during the 4th quarter valued at $28,000. IMG Wealth Management Inc. bought a new stake in shares of Synopsys during the 1st quarter worth $30,000. Finally, Atlas Capital Advisors Inc. bought a new stake in shares of Synopsys during the 4th quarter worth $32,000. Hedge funds and other institutional investors own 85.47% of the company's stock.

Analysts Set New Price Targets

A number of research analysts recently commented on SNPS shares. Citigroup increased their target price on Synopsys from $600.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, May 28th. Morgan Stanley lifted their price target on Synopsys from $480.00 to $525.00 and gave the stock an "equal weight" rating in a research note on Thursday, May 28th. Rosenblatt Securities increased their price objective on Synopsys from $530.00 to $575.00 and gave the company a "buy" rating in a research report on Tuesday, May 26th. Piper Sandler raised Synopsys from a "neutral" rating to an "overweight" rating and raised their price objective for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. Finally, Zacks Research upgraded Synopsys from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, June 30th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $570.06.

Read Our Latest Stock Analysis on Synopsys

Synopsys Stock Performance

Synopsys stock opened at $388.76 on Friday. The firm has a fifty day simple moving average of $443.88 and a two-hundred day simple moving average of $450.68. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $646.28. The company has a market capitalization of $74.44 billion, a PE ratio of 89.99, a P/E/G ratio of 2.28 and a beta of 1.22.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion for the quarter, compared to analysts' expectations of $2.25 billion. During the same period last year, the firm earned $3.67 earnings per share. The company's revenue for the quarter was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.

Insider Buying and Selling

In related news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares of the company's stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company's stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company's stock, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company's stock.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines